SCHEMBL10080799

SCHEMBL10080799

C=CC(=O)OC(CCCC)CCCCCCC

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.50
HPGD P15428 1/20 0.47
CA2 P00918 1/20 0.42
THRB P10828 2/20 0.41
ZDHHC20 Q5W0Z9 2/20 0.41
ZDHHC2 Q9UIJ5 2/20 0.41
CTSK P43235 1/20 0.41
GPR84 Q9NQS5 3/20 0.40
THRA P10827 1/20 0.40
FFAR1 O14842 1/20 0.40
MAPT P10636 2/20 0.40
ZDHHC7 Q9NXF8 1/20 0.40
MAPK1 P28482 1/20 0.40
LCK P06239 1/20 0.39
PPARD Q03181 1/20 0.39
HCAR2 Q8TDS4 1/20 0.39
ALDH1A1 P00352 1/20 0.38
CYP3A4 P08684 1/20 0.38
FAAH O00519 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31456184 1.00 TSHR (0.50) TSHRHPGDCA2THRBZDHHC20
SCHEMBL867648 1.00 TSHR (0.50) TSHRHPGDCA2THRBZDHHC20
SCHEMBL7537024 1.00 TSHR (0.50) TSHRHPGDCA2THRBZDHHC20
SCHEMBL31742396 1.00 TSHR (0.50) TSHRHPGDCA2THRBZDHHC20
SCHEMBL18134827 0.98 TSHR (0.48) TSHRHPGDTHRBZDHHC20ZDHHC2
SCHEMBL7125959 0.98 TSHR (0.48) TSHRHPGDTHRBZDHHC20ZDHHC2
SCHEMBL7649106 0.98 TSHR (0.48) TSHRHPGDTHRBZDHHC20ZDHHC2
SCHEMBL6357521 0.98 TSHR (0.48) TSHRHPGDTHRBZDHHC20ZDHHC2
SCHEMBL21647292 0.98 TSHR (0.48) TSHRHPGDTHRBZDHHC20ZDHHC2
SCHEMBL7864075 0.98 TSHR (0.51) TSHRHPGDCA2THRBZDHHC20

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022211003-A1 LUBRICATING OIL ADDITIVE COMPOSITION AND LUBRICATING OIL COMPOSITION 出光興産株式会社 2022-10-06 WO disclosed
CN-114174299-A Degradation of Bruton's Tyrosine Kinase (BTK) by conjugation of BTK inhibitors to E3 ligase ligands and methods of use 百济神州有限公司 2022-03-11 CN disclosed
CN-111718259-A Process for preparing (meth) acrylic esters of bioalcohols and polymers thereof 3M创新有限公司 2020-09-29 CN disclosed
EP-2970093-B1 METHOD FOR PREPARING (METH)ACRYLATES OF BIOBASED ALCOHOLS AND POLYMERS THEREOF 3M INNOVATIVE PROPERTIES CO (US) 2018-12-12 EP disclosed
US-9908837-B2 Method for preparing (meth)acrylates of biobased alcohols and polymers thereof 3M INNOVATIVE PROPERTIES COMPANY (US) 2018-03-06 US disclosed
EP-2970093-A1 METHOD FOR PREPARING (METH)ACRYLATES OF BIOBASED ALCOHOLS AND POLYMERS THEREOF 3M Innovative Properties Company (US) 2016-01-20 EP disclosed
US-20160009628-A1 METHOD FOR PREPARING (METH)ACRYLATES OF BIOBASED ALCOHOLS AND POLYMERS THEREOF 3M INNOVATIVE PROPERTIES COMPANY (US) 2016-01-14 US disclosed
US-9102774-B2 Polymers derived from secondary alkyl (meth)acrylates 3M INNOVATIVE PROPERTIES COMPANY (US) 2015-08-11 US disclosed
US-9102774-B2 Polymers derived from secondary alkyl (meth)acrylates 3M INNOVATIVE PROPERTIES COMPANY (US) 2015-08-11 US disclosed
EP-2655451-B1 POLYMERS DERIVED FROM SECONDARY ALKYL (METH)ACRYLATES 3M INNOVATIVE PROPERTIES CO (US) 2015-03-11 EP disclosed
WO-2014151179-A1 METHOD FOR PREPARING (METH)ACRYLATES OF BIOBASED ALCOHOLS AND POLYMERS THEREOF 3M INNOVATIVE PROPERTIES COMPANY (US) 2014-09-25 WO disclosed
WO-2014143690-A1 METHOD FOR PREPARING (METH)ACRYLATES OF BIOBASED ALCOHOLS AND POLYMERS THEREOF 3M INNOVATIVE PROPERTIES COMPANY (US) 2014-09-18 WO disclosed
US-20130260149-A1 POLYMERS DERIVED FROM SECONDARY ALKYL (METH)ACRYLATES 3M INNOVATIVE PROPERTIES COMPANY 2013-10-03 US disclosed
US-20130260149-A1 POLYMERS DERIVED FROM SECONDARY ALKYL (METH)ACRYLATES 3M INNOVATIVE PROPERTIES COMPANY 2013-10-03 US disclosed
WO-2012088126-A1 POLYMERS DERIVED FROM SECONDARY ALKYL (METH)ACRYLATES 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160009628-A1 METHOD FOR PREPARING (METH)ACRYLATES OF BIOBASED ALCOHOLS AND POLYMERS THEREOF ADH1A, ADH1C, ADH5 TSHR 4523/4885HPGD 499/4885CA2 3258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.